The study found that patients who experienced significant nausea and reduced caloric intake showed measurable decreases in serum sodium and potassium compared to baseline, with symptoms that overlapped significantly with commonly reported GLP-1 side effects
Additional generic applications from Sandoz and Teva remain under Health Canada review, which is expected to push prices down further
Tirzepatide, an FDA-approved weight loss injection, mimics the action of two hormones naturally responsible for regulating your appetite and blood sugar: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
It occurs due to inflammation and irritation at the site of injection
It's a melanocortin receptor agonist meaning it activates specific receptors (melanocortin receptors, specifically MC3R and MC4R) in the hypothalamus, the part of your brain that controls sexual desire, arousal, and hormonal signals